ID

33511

Description

Study ID: 104297 Clinical Study ID: 104297 Study Title: An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00323622 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: SB257049 Study Indication: Malaria

Mots-clés

Versions (3)
  1. 11/12/2018 11/12/2018 -
  2. 06/06/2019 06/06/2019 -
  3. 12/06/2019 12/06/2019 -
Détendeur de droits

GSK group of companies

Téléchargé le

11 décembre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Immunogenicity of malaria vaccine candidate in Mozambican children (1 to 4 y.o) - 104297 (Malaria039)

Anglais

Study Conclusion

1 Formulaires  
  1. StudyEvent: ODM
    1. Study Conclusion
Administrative data
Description

Administrative data

Protocol Number
Description

Protocol Number

Type de données

integer

Subject Number
Description

Subject Number

Type de données

integer

Occurrence of serious adverse event
Description

Occurrence of serious adverse event

Did the subject experience any Serious Adverse Event since Visit 7, Month 21 of Malaria-026 study?
Description

SAEs recorded up to Visit 7, Month 21 of Malaria-026 to be recorded in Malaria-026 SAE forms; SAEs recorded 1 day after Visit 7, Month 21 to be recorded in Malaria-039 SAE forms

Type de données

boolean

If Yes, specify total number of SAE's for the Malaria-039 period only
Description

If Yes, specify total number of SAE's for the Malaria-039 period only

Type de données

integer

Subject Withdrawal
Description

Subject Withdrawal

Is the subject withdrawn from the study?
Description

A subject is withdrawn from interim analysis if he/she did not come for the interim analysis timepoint visit

Type de données

boolean

If Yes, choose one reason for withdrawal
Description

If Yes, choose one reason for withdrawal

Type de données

text

If Death, please specify SAE number
Description

If Death, please specify SAE number

Type de données

integer

Is Serious Adverse Event, please specify the SAE number
Description

Is Serious Adverse Event, please specify the SAE number

Type de données

integer

If Protocol violation, please specify
Description

If Protocol violation, please specify

Type de données

text

If Other, please specify
Description

If Other, please specify

Type de données

text

Who made the decision?
Description

Who made the decision?

Type de données

text

Date of last contact
Description

Date of last contact

Type de données

date

Was the subject in good condition at date of last contact?
Description

Was the subject in good condition at date of last contact?

Type de données

boolean

If No, please give details in Adverse Event section.
Description

If No, please give details in Adverse Event section.

Type de données

text

Investigator's Signature
Description

Investigator's Signature

I confirm that I have reviewed the data in this Case Report for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
Description

Investigator's confirmation

Type de données

date

Investigator's signature
Description

Investigator's signature

Type de données

text

Investigator's name (in print)
Description

Investigator's name (in print)

Type de données

text

Retour au début de la page

Similar models

Study Conclusion

1 Formulaires
  1. StudyEvent: ODM
    1. Study Conclusion
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative data
Protocol Number
Item
Protocol Number
integer
Subject Number
Item
Subject Number
integer
Item Group
Occurrence of serious adverse event
Did the subject experience any Serious Adverse Event since Visit 7, Month 21 of Malaria-026 study?
Item
Did the subject experience any Serious Adverse Event since Visit 7, Month 21 of Malaria-026 study?
boolean
If Yes, specify total number of SAE's for the Malaria-039 period only
Item
If Yes, specify total number of SAE's for the Malaria-039 period only
integer
Item Group
Subject Withdrawal
Is the subject withdrawn from the study?
Item
Is the subject withdrawn from the study?
boolean
Item
If Yes, choose one reason for withdrawal
text
If Yes, choose one reason for withdrawal
Code List
If Yes, choose one reason for withdrawal
CL Item
Death (1)
CL Item
Serious adverse event (2)
CL Item
Protocol violation, please specify (3)
CL Item
Consent withdrawal not due to an adverse event (4)
CL Item
Migrated/moved from the study area (5)
CL Item
Lost to follow-up (6)
CL Item
Other (7)
If Death, please specify SAE number
Item
If Death, please specify SAE number
integer
Is Serious Adverse Event, please specify the SAE number
Item
Is Serious Adverse Event, please specify the SAE number
integer
If Protocol violation, please specify
Item
If Protocol violation, please specify
text
If Other, please specify
Item
If Other, please specify
text
Item
Who made the decision?
text
Who made the decision?
Code List
Who made the decision?
CL Item
Investigator (1)
CL Item
Parents/Guardians (2)
Date of last contact
Item
Date of last contact
date
Was the subject in good condition at date of last contact?
Item
Was the subject in good condition at date of last contact?
boolean
If No, please give details in Adverse Event section.
Item
If No, please give details in Adverse Event section.
text
Item Group
Investigator's Signature
Investigator's confirmation
Item
I confirm that I have reviewed the data in this Case Report for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
date
Investigator's signature
Item
Investigator's signature
text
Investigator's name (in print)
Item
Investigator's name (in print)
text
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial